Silvia Vázquez

795 total citations
29 papers, 483 citations indexed

About

Silvia Vázquez is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silvia Vázquez has authored 29 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Otorhinolaryngology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silvia Vázquez's work include Head and Neck Cancer Studies (10 papers), Breast Cancer Treatment Studies (6 papers) and Head and Neck Surgical Oncology (5 papers). Silvia Vázquez is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Breast Cancer Treatment Studies (6 papers) and Head and Neck Surgical Oncology (5 papers). Silvia Vázquez collaborates with scholars based in Spain, United States and Palestinian Territory. Silvia Vázquez's co-authors include Manuel O. Landázuri, Ángel Ordóñez, Ricard Mesı́a, Luis del Peso, Mar Garcı́a-Rocha, Nuria Pescador, Joan J. Guinovart, Daniel Cifuentes, Laura García‐Bermejo and Yolanda Cuevas and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Silvia Vázquez

29 papers receiving 479 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Silvia Vázquez 182 170 116 114 110 29 483
John R. Houck 179 1.0× 330 1.9× 138 1.2× 128 1.1× 161 1.5× 22 771
Y Kawarada 140 0.8× 200 1.2× 156 1.3× 11 0.1× 118 1.1× 26 592
Y. Bian 164 0.9× 302 1.8× 175 1.5× 16 0.1× 54 0.5× 10 529
Mingwei Zhang 128 0.7× 151 0.9× 174 1.5× 183 1.6× 197 1.8× 42 543
Cuizhen Li 175 1.0× 321 1.9× 122 1.1× 9 0.1× 209 1.9× 20 627
Bruno Jim Rocca 97 0.5× 157 0.9× 127 1.1× 9 0.1× 70 0.6× 40 441
Shigenori Furukawa 115 0.6× 162 1.0× 138 1.2× 20 0.2× 59 0.5× 42 449
Morito Monden 86 0.5× 301 1.8× 145 1.3× 6 0.1× 112 1.0× 19 635
Riccardo Lobefaro 140 0.8× 131 0.8× 265 2.3× 9 0.1× 112 1.0× 31 494
Emanuele Cotroneo 105 0.6× 282 1.7× 55 0.5× 9 0.1× 341 3.1× 9 714

Countries citing papers authored by Silvia Vázquez

Since Specialization
Citations

This map shows the geographic impact of Silvia Vázquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Vázquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Vázquez more than expected).

Fields of papers citing papers by Silvia Vázquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Vázquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Vázquez. The network helps show where Silvia Vázquez may publish in the future.

Co-authorship network of co-authors of Silvia Vázquez

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Vázquez. A scholar is included among the top collaborators of Silvia Vázquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Vázquez. Silvia Vázquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stradella, Agostina, Anna Petit, Sabela Recalde, et al.. (2022). Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern Pathology. 35(8). 1066–1074. 5 indexed citations
3.
4.
Stradella, Agostina, Jenniffer Linares, Sabela Recalde, et al.. (2021). Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases. Clinical & Translational Oncology. 23(9). 1761–1768. 4 indexed citations
5.
Pernas, Sònia, Audrey Petit, Ander Urruticoechea, et al.. (2021). 14P Immunomodulatory effect of denosumab in early breast cancer: Preliminary results of a randomized window-opportunity clinical trial D-Biomark. Annals of Oncology. 32. S26–S26. 1 indexed citations
6.
Fernández-Mateos, Javier, Ricard Mesı́a, Jordi Rubió‐Casadevall, et al.. (2020). Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial. Scientific Reports. 10(1). 16634–16634. 12 indexed citations
7.
Stradella, Agostina, Idoia Morilla, Catalina Falo, et al.. (2019). Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center. BMC Pharmacology and Toxicology. 20(1). 68–68. 7 indexed citations
8.
Soler, G., Irune Ruiz, Silvia Vázquez, et al.. (2018). Detection of frailty in elderly colorectal càncer patients: Is G8 a good screening tool?. Annals of Oncology. 29. viii191–viii191. 1 indexed citations
9.
Plana, Nieves, et al.. (2017). Does hyper-progression exist among head and neck cancer patients treated with immunotherapy?. Annals of Oncology. 28. v379–v379. 3 indexed citations
10.
Arribas, Lorena, Miren Taberna, Inmaculada Peiró, et al.. (2017). Nutritional changes in patients with locally advanced head and neck cancer during treatment. Oral Oncology. 71. 67–74. 56 indexed citations
11.
12.
Montal, Robert, Marc Oliva, Miren Taberna, et al.. (2016). Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab. Clinical & Translational Oncology. 18(11). 1140–1146. 3 indexed citations
13.
Taberna, Miren, Antonio Rullan, Cinta Hierro, et al.. (2015). Late toxicity after radical treatment for locally advanced head and neck cancer. Oral Oncology. 51(8). 795–799. 29 indexed citations
14.
Mesı́a, Ricard, Silvia Vázquez, Juan J. Grau, et al.. (2015). A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 94(2). 289–296. 22 indexed citations
15.
Rivera, Fernando, Bartomeu Massutí, Javier Sastre, et al.. (2013). Phase II trial of miniDOX (reduced-dose docetaxel/oxaliplatin/capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC): TTD 08-02.. Journal of Clinical Oncology. 31(4_suppl). 87–87. 1 indexed citations
16.
Elorza, Ainara, Inés Soro-Arnáiz, Ángel Ordóñez, et al.. (2011). Acute Vhl Gene Inactivation Induces Cardiac HIF-Dependent Erythropoietin Gene Expression. PLoS ONE. 6(7). e22589–e22589. 25 indexed citations
17.
Mesı́a, Ricard, Ramón Palmero, Mònica Cos, Esther Vilajosana, & Silvia Vázquez. (2010). Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report. Head & Neck Oncology. 2(1). 3–3. 6 indexed citations
18.
Pescador, Nuria, Diego Villar, Daniel Cifuentes, et al.. (2010). Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1. PLoS ONE. 5(3). e9644–e9644. 208 indexed citations
19.
Ramos, Ana, Marta Albalate, Silvia Vázquez, et al.. (2008). Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. Kidney International. 74(111). S88–S93. 22 indexed citations
20.
Esteban, Miguel A., Salvador Naranjo‐Suarez, María C. Castellanos, et al.. (2008). Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells. Journal of Biological Chemistry. 283(36). 24982–24990. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John R. Houck Breakdown of academic impact, for papers by Y Kawarada Breakdown of academic impact, for papers by Y. Bian Breakdown of academic impact, for papers by Mingwei Zhang Breakdown of academic impact, for papers by Cuizhen Li Breakdown of academic impact, for papers by Bruno Jim Rocca Breakdown of academic impact, for papers by Shigenori Furukawa Breakdown of academic impact, for papers by Morito Monden Breakdown of academic impact, for papers by Riccardo Lobefaro Breakdown of academic impact, for papers by Emanuele Cotroneo
Rankless by CCL
2026